Frontiers in Pharmacology | Respiratory Pharmacology

Clinical Trial

Published on 19 Jan 2023

Huashi baidu granule in the treatment of pediatric patients with mild coronavirus disease 2019: A single-center, open-label, parallel-group randomized controlled clinical trial

in Respiratory Pharmacology

Jiande Chen
Qiuyu Tang
Baoqin Zhang
Shuhua Yuan
Jia Chen
Shiyu Shen
Dong Wang
Jilei Lin
Hongliang Dong
Yong Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1092748

2,644 views
5 citations

Editorial

Published on 16 Jan 2023

Editorial: Pathophysiological and clinical advances in asthmatic inflammation from the nasopharynx to the peripheral airway in the respiratory tract systems

in Respiratory Pharmacology

Yasuhiko Koga
Yosuke Kamide
Takeshi Hisada
Tamotsu Ishizuka

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1037610

1,523 views

Mini Review

Published on 13 Jan 2023

Open questions in human lung organoid research

in Respiratory Pharmacology

Tessa Hughes
Krijn K. Dijkstra
Emma L. Rawlins
Robert E. Hynds

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1083017

6,676 views
9 citations

Original Research

Published on 12 Jan 2023

Fast cycling of intermittent hypoxia in a physiomimetic 3D environment: A novel tool for the study of the parenchymal effects of sleep apnea

in Respiratory Pharmacology

Alicia Jurado
Anna Ulldemolins
Helena Lluís
Xavier Gasull
Núria Gavara
Raimon Sunyer
Jorge Otero
David Gozal
Isaac Almendros
Ramon Farré

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1081345

2,294 views

Original Research

Published on 09 Jan 2023

Dang Gui Bu Xue Tang, a conventional Chinese herb decoction, ameliorates radiation-induced heart disease via Nrf2/HMGB1 pathway

in Respiratory Pharmacology

Yifan Huang
Minghan Cheng
Xiaoye Wang
Hongliang Dong
Jian Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1086206

3,326 views
8 citations

Original Research

Published on 06 Jan 2023

Tetramethylpyrazine ameliorates acute lung injury by regulating the Rac1/LIMK1 signaling pathway

in Respiratory Pharmacology

Simin Min
Weiting Tao
Dushan Ding
Xiaonan Zhang
Shidi Zhao
Yong Zhang
Xiaojie Liu
Kefei Gao
Saisai Liu
Li Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1005014

4,023 views
14 citations

Original Research

Published on 06 Jan 2023

Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats

in Respiratory Pharmacology

Huanjie Chen
Yulong Luo
Yiping Zhu
Yongshun Ye
Difei Chen
Xinyu Song
Zhulin Xiao
Ming Liu
Shiyue Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1070736

2,957 views
12 citations

Correction

Published on 04 Jan 2023

Corrigendum: Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial

in Respiratory Pharmacology

Qinhai Ma
Ruihan Chen
Jing Zeng
Biao Lei
Feng Ye
Qihua Wu
Zhengtu Li
Yangqing Zhan
Bin Liu
Bojun Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1036927

1,366 views
2 citations

Original Research

Published on 22 Dec 2022

FGF10 ameliorates lipopolysaccharide-induced acute lung injury in mice via the BMP4-autophagy pathway

in Respiratory Pharmacology

Xiaoxia Kong
Liling Lu
Daopeng Lin
Lei Chong
Shunhang Wen
Yaokai Shi
Lidan Lin
Liqin Zhou
Hongyu Zhang
Hailin Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1019755

4,284 views
6 citations

Correction

Published on 16 Dec 2022

Corrigendum: Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis

in Respiratory Pharmacology

Guirui Huang
Shuaiyang Huang
Hongsheng Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1117317

1,120 views

Review

Published on 12 Dec 2022

Emerging toolset of three-dimensional pulmonary cell culture models for simulating lung pathophysiology towards mechanistic elucidation and therapeutic treatment of SARS-COV-2 infection

in Respiratory Pharmacology

Kai Ni
Bo Che
Chongxin Yang
Youyuan Qin
Rong Gu
Chunhong Wang
Mingzhi Luo
Linhong Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1033043

3,793 views
3 citations

Editorial

Published on 07 Dec 2022

Editorial: Antiviral drugs and vaccines against important human respiratory viruses

in Respiratory Pharmacology

Minghui Yang
Yang Yang
Qingbing Zheng
Khrustalev Vladislav Victorovich
Chenguang Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1082652

1,281 views

Correction

Published on 02 Dec 2022

Corrigendum: Danshensu methyl ester enhances autophagy to attenuate pulmonary fibrosis by targeting lncIAPF–HuR complex

in Respiratory Pharmacology

Qi Zhu
Jing Wang
Yunxia Ji
Jianlin Luan
Dayong Yue
Weili Liu
Hongbo Li
Jinjin Zhang
Guiwu Qu
Changjun Lv

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1086927

1,853 views

Review

Published on 02 Dec 2022

Human matters in asthma: Considering the microbiome in pulmonary health

in Respiratory Pharmacology

Sandesh J. Marathe
Mark A. Snider
Armando S. Flores-Torres
Patricia J. Dubin
Amali E. Samarasinghe

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1020133

7,051 views
8 citations

Original Research

Published on 29 Nov 2022

Inhaled platelet vesicle-decoyed biomimetic nanoparticles attenuate inflammatory lung injury

in Respiratory Pharmacology

Hua Jin
Renxing Luo
Jianing Li
Hongxia Zhao
Suidong Ouyang
Yinlian Yao
Dongyan Chen
Zijie Ling
Weicong Zhu
Meijun Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1050224

6,640 views
15 citations

Original Research

Published on 29 Nov 2022

Analysis of the safety and efficacy of different plasma concentrations of pirfenidone in patients with idiopathic pulmonary fibrosis

in Respiratory Pharmacology

Hui Li
Jing Yang
Shanshan Chen
Peile Wang
Xueqing Yu
Qingwei Zhou
Xiaojian Zhang
Guojun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1055702

2,660 views
5 citations